Since this epidermal degeneration is linked to ECM damage/modification and inflammation, the in-vitro approaches consisted in the evaluation of HHA/BC hydrogels as anti-inflammatory agents on TNF-α treated fibroblasts [32]. This evidence concerns the gene TNF and breast cancer.